Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics), By Phase (Phase I, II, III, IV), By Region (APAC, North America), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Clinical Trial Equipment & Ancillary Solutions Market Growth & Trends
The global clinical trial equipment & ancillary solutions market is expected to reach USD 5.09 billion by 2030, expanding at a CAGR of 8.1% over the forecast period according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market. However, The COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of the equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments that were in progress before the pandemic was halted due to COVID-19 globally.
The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites. As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations.
The pandemic has created a need for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitization of healthcare and the adoption of cutting-edge technologies and techniques. Such adoptions are likely to propel market growth. Moreover, the high R&D spending by the pharmaceutical company for developing innovative therapies for COVID-19 have further contributed to the market growth.
Clinical Trial Equipment & Ancillary Solutions Market Report Highlights
Clinical Trial Equipment & Ancillary Solutions Market Growth & Trends
The global clinical trial equipment & ancillary solutions market is expected to reach USD 5.09 billion by 2030, expanding at a CAGR of 8.1% over the forecast period according to a new report by Grand View Research, Inc. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market. However, The COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of the equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments that were in progress before the pandemic was halted due to COVID-19 globally.
The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites. As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations.
The pandemic has created a need for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitization of healthcare and the adoption of cutting-edge technologies and techniques. Such adoptions are likely to propel market growth. Moreover, the high R&D spending by the pharmaceutical company for developing innovative therapies for COVID-19 have further contributed to the market growth.
Clinical Trial Equipment & Ancillary Solutions Market Report Highlights
- The supply/logistics product segment dominated the market with a revenue share of more than 38% in 2021 due to the high number of clinical trials globally, which resulted in increased demand for efficient logistics services
- The phase III segment accounted for the maximum revenue share of 53.9% in the global market in 2021. Phase III studies are the most effective approach to discovering a new treatment standard
- North America led the global market in 2021 and is expected to remain dominant even during the forecast years due to a rise in the number of CRO and pharmaceutical & medical companies in the region
- Asia Pacific is projected to be the registered fastest-growing CAGR of 9.5% during the forecast period as it is becoming an increasingly significant site for clinical trial investigations.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
CHAPTER 3 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Evolving Clinical Trials Needs
3.3.1.2 Rising Investment In R&D
3.3.1.3 Growing Pharmaceutical & Medical Devices Industry
3.3.2 Market Restraint Analysis
3.3.2.1 Rising Cost Of Clinical Trials
3.4 Porter’s Five Forces Analysis
3.5 Pestel Analysis
3.6 Major Deals & Strategic Alliances Analysis
3.7 Covid Impact Analysis
3.8 Revenues Of Major Companies In Clinical Trial Equipment & Ancillary Solutions
3.9 Revenue Split By Product Segment For Major Companies
CHAPTER 4 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: PRODUCT SEGMENT ANALYSIS
4.1 Clinical Trial Equipment Ancillary Solutions Market: Definition & Scope
4.2 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis, 2021 & 2030
4.3 Sourcing
4.3.1 Sourcing Market, 2018 - 2030 (Usd Million)
4.3.2 Procurement
4.3.2.1 Procurement Market, 2018 - 2030 (Usd Million)
4.3.2.2 Equipment
4.3.2.2.1 Equipment Market, 2018 - 2030 (Usd Million)
4.3.2.2.2 Ancillaries
4.3.2.2.2.1 Ancillaries Market, 2018 - 2030 (Usd Million)
4.3.2.3 Rental
4.3.2.3.1 Rental Market, 2018 - 2030 (Usd Million)
4.3.2.3.2 Equipment
4.3.2.3.2.1 Equipment Market, 2018 - 2030 (Usd Million)
4.3.2.3.3 Ancillaries
4.3.2.3.3.1 Ancillaries Market, 2018 - 2030 (Usd Million)
4.4 Supply/Logistics
4.4.1 Supply/Logistics Market, 2018 - 2030 (Usd Million)
4.4.2 Transportation
4.4.2.1 Transportation Market, 2018 - 2030 (Usd Million)
4.4.3 Packaging
4.4.3.1 Packaging Market, 2018 - 2030 (Usd Million)
4.4.4 Others
4.4.4.1 Others Market, 2018 - 2030 (Usd Million)
4.5 Service
4.5.1 Service Market, 2018 - 2030 (Usd Million)
4.5.2 Calibration
4.5.2.1 Calibration Market, 2018 - 2030 (Usd Million)
4.5.3 Equipment Servicing
4.5.3.1 Equipment Servicing Market, 2018 - 2030 (Usd Million)
4.5.4 Others
4.5.4.1 Others Market, 2018 - 2030 (Usd Million)
4.6 Others
4.6.1 Others Market, 2018 - 2030 (Usd Million)
CHAPTER 5 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: PHASEANALYSIS
5.1 Clinical Trial Equipment Ancillary Solutions Market: Definition & Scope
5.2 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis, 2021 & 2030
5.3 Phase I
5.3.1 Phase I Market, 2018 - 2030 (Usd Million)
5.4. Phase Ii
5.4.1 Phase Ii Market, 2018 - 2030 (Usd Million)
5.5 Phase Iii
5.5.1. Phase Iii Market, 2018 - 2030 (Usd Million)
5.6 Phase Iv
5.6.1. Phase Iv Market, 2018 - 2030 (Usd Million)
CHAPTER 6 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: REGIONAL ANALYSIS
6.1 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis
6.2 North America
6.2.1 North America Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.2.2 The U.S.
6.2.2.1 The U.S. Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.2 The U.K.
6.3.2.1 The U.K. Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.4 France
6.3.4.1 France Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.2 India
6.4.2.1 India Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.3 Japan
6.4.3.1 Japan Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.4 China
6.4.4.1 China Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.5 Australia
6.4.5.1 Australia Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5.5 Colombia
6.5.5.1 Colombia Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.6 Mea
6.6.1 Mea Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia Clinical Trial Equipment & Ancillary Solutions market, 2018-2030(USD Million)
6.6.4 UAE
6.6.4.1 UAE Clinical Trial Equipment & Ancillary Solutions market, 2018-2030(USD Million)
CHAPTER 7 COMPANY PROFILES
7.1 Company Profiles
7.1.1 Ancillare LP
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Service benchmarking
7.1.1.4 Strategic initiative
7.1.2 Imperial CRS
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Service benchmarking
7.1.3 Woodley Equipment Company Ltd
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Service benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Thermo Fisher Scientific Inc.
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 PPD, Inc
7.1.5.1 Company overview
7.1.5.2 Product benchmarking
7.1.5.3 Strategic initiatives
7.1.6 Parexel International Corporation
7.1.6.1 Company overview
7.1.6.2 Product benchmarking
7.1.6.3 Strategic initiatives
7.1.7 MediCapital Rent (EMsere)
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Quipment SAS
7.1.8.1 Company overview
7.1.8.2 Financial performance
7.1.8.3 Product benchmarking
7.1.9 IRM
7.1.9.1 Company overview
7.1.9.2 Financial performance
7.1.9.3 Product benchmarking
7.1.10 MARKEN A UPS COMPANy
7.1.10.1 Company overview
7.1.10.2 Financial performance
7.1.10.3 Product benchmarking
7.1.10.4 Strategic initiatives
7.1.11 MYONEX
7.1.11.1 Company overview
7.1.11.2 Financial performance
7.1.11.3 Product benchmarking
71.11.4 Strategic initiatives
7.1.12 Yourway
7.1.12.1 Company overview
7.1.12.2 Financial performance
7.1.12.3 Product benchmarking
7.1.12.4 Strategic initiatives
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List Of Secondary Sources
1.8 List Of Primary Sources
1.9 List Of Abbreviations
1.10 Objectives
1.10.1 Objective -
1.10.2 Objective -
1.10.3 Objective -
1.10.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
CHAPTER 3 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Evolving Clinical Trials Needs
3.3.1.2 Rising Investment In R&D
3.3.1.3 Growing Pharmaceutical & Medical Devices Industry
3.3.2 Market Restraint Analysis
3.3.2.1 Rising Cost Of Clinical Trials
3.4 Porter’s Five Forces Analysis
3.5 Pestel Analysis
3.6 Major Deals & Strategic Alliances Analysis
3.7 Covid Impact Analysis
3.8 Revenues Of Major Companies In Clinical Trial Equipment & Ancillary Solutions
3.9 Revenue Split By Product Segment For Major Companies
CHAPTER 4 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: PRODUCT SEGMENT ANALYSIS
4.1 Clinical Trial Equipment Ancillary Solutions Market: Definition & Scope
4.2 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis, 2021 & 2030
4.3 Sourcing
4.3.1 Sourcing Market, 2018 - 2030 (Usd Million)
4.3.2 Procurement
4.3.2.1 Procurement Market, 2018 - 2030 (Usd Million)
4.3.2.2 Equipment
4.3.2.2.1 Equipment Market, 2018 - 2030 (Usd Million)
4.3.2.2.2 Ancillaries
4.3.2.2.2.1 Ancillaries Market, 2018 - 2030 (Usd Million)
4.3.2.3 Rental
4.3.2.3.1 Rental Market, 2018 - 2030 (Usd Million)
4.3.2.3.2 Equipment
4.3.2.3.2.1 Equipment Market, 2018 - 2030 (Usd Million)
4.3.2.3.3 Ancillaries
4.3.2.3.3.1 Ancillaries Market, 2018 - 2030 (Usd Million)
4.4 Supply/Logistics
4.4.1 Supply/Logistics Market, 2018 - 2030 (Usd Million)
4.4.2 Transportation
4.4.2.1 Transportation Market, 2018 - 2030 (Usd Million)
4.4.3 Packaging
4.4.3.1 Packaging Market, 2018 - 2030 (Usd Million)
4.4.4 Others
4.4.4.1 Others Market, 2018 - 2030 (Usd Million)
4.5 Service
4.5.1 Service Market, 2018 - 2030 (Usd Million)
4.5.2 Calibration
4.5.2.1 Calibration Market, 2018 - 2030 (Usd Million)
4.5.3 Equipment Servicing
4.5.3.1 Equipment Servicing Market, 2018 - 2030 (Usd Million)
4.5.4 Others
4.5.4.1 Others Market, 2018 - 2030 (Usd Million)
4.6 Others
4.6.1 Others Market, 2018 - 2030 (Usd Million)
CHAPTER 5 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: PHASEANALYSIS
5.1 Clinical Trial Equipment Ancillary Solutions Market: Definition & Scope
5.2 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis, 2021 & 2030
5.3 Phase I
5.3.1 Phase I Market, 2018 - 2030 (Usd Million)
5.4. Phase Ii
5.4.1 Phase Ii Market, 2018 - 2030 (Usd Million)
5.5 Phase Iii
5.5.1. Phase Iii Market, 2018 - 2030 (Usd Million)
5.6 Phase Iv
5.6.1. Phase Iv Market, 2018 - 2030 (Usd Million)
CHAPTER 6 CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET: REGIONAL ANALYSIS
6.1 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis
6.2 North America
6.2.1 North America Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.2.2 The U.S.
6.2.2.1 The U.S. Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.2 The U.K.
6.3.2.1 The U.K. Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.4 France
6.3.4.1 France Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.2 India
6.4.2.1 India Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.3 Japan
6.4.3.1 Japan Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.4 China
6.4.4.1 China Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.5 Australia
6.4.5.1 Australia Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.5.5 Colombia
6.5.5.1 Colombia Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.6 Mea
6.6.1 Mea Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Clinical Trial Equipment & Ancillary Solutions Market, 2018 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia Clinical Trial Equipment & Ancillary Solutions market, 2018-2030(USD Million)
6.6.4 UAE
6.6.4.1 UAE Clinical Trial Equipment & Ancillary Solutions market, 2018-2030(USD Million)
CHAPTER 7 COMPANY PROFILES
7.1 Company Profiles
7.1.1 Ancillare LP
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Service benchmarking
7.1.1.4 Strategic initiative
7.1.2 Imperial CRS
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Service benchmarking
7.1.3 Woodley Equipment Company Ltd
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Service benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Thermo Fisher Scientific Inc.
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 PPD, Inc
7.1.5.1 Company overview
7.1.5.2 Product benchmarking
7.1.5.3 Strategic initiatives
7.1.6 Parexel International Corporation
7.1.6.1 Company overview
7.1.6.2 Product benchmarking
7.1.6.3 Strategic initiatives
7.1.7 MediCapital Rent (EMsere)
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Product benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Quipment SAS
7.1.8.1 Company overview
7.1.8.2 Financial performance
7.1.8.3 Product benchmarking
7.1.9 IRM
7.1.9.1 Company overview
7.1.9.2 Financial performance
7.1.9.3 Product benchmarking
7.1.10 MARKEN A UPS COMPANy
7.1.10.1 Company overview
7.1.10.2 Financial performance
7.1.10.3 Product benchmarking
7.1.10.4 Strategic initiatives
7.1.11 MYONEX
7.1.11.1 Company overview
7.1.11.2 Financial performance
7.1.11.3 Product benchmarking
71.11.4 Strategic initiatives
7.1.12 Yourway
7.1.12.1 Company overview
7.1.12.2 Financial performance
7.1.12.3 Product benchmarking
7.1.12.4 Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 1 List of secondary sources
Table 2 List of abbreviations
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Volume price analysis
Fig. 9 Clinical trial equipment & ancillary solutions market snapshot (2021)
Fig. 10 Clinical trial equipment & ancillary solutions market segmentation
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Number of registered studies by year
Fig. 19 Revenue By Product (USD Million)
Fig. 20 Revenue By Product (USD Million)
Fig. 21 Clinical trial equipment & ancillary solutions market product outlook: Segment dashboard
Fig. 22 Clinical trial equipment & ancillary solutions market: Product movement analysis
Fig. 23 Sourcing market, 2018 - 2030 (USD Million)
Fig. 24 Procurement market, 2018 - 2030 (USD Million)
Fig. 25 Equipment market, 2018 - 2030 (USD Million)
Fig. 26 Ancillaries market, 2018 - 2030 (USD Million)
Fig. 27 Rental market, 2018 - 2030 (USD Million)
Fig. 28 Equipment market, 2018 - 2030 (USD Million)
Fig. 29 Ancillaries market, 2018 - 2030 (USD Million)
Fig. 30 Supply/logistics market, 2018 - 2030 (USD Million)
Fig. 31 Transportation market, 2018 - 2030 (USD Million)
Fig. 32 Packaging market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Service market, 2018 - 2030 (USD Million)
Fig. 35 Calibration market, 2018 - 2030 (USD Million)
Fig. 36 Equipment servicing market, 2018 - 2030 (USD Million)
Fig. 37 Others market, 2018 - 2030 (USD Million)
Fig. 38 Others market, 2018 - 2030 (USD Million)
Fig. 39 Global market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Volume price analysis
Fig. 9 Clinical trial equipment & ancillary solutions market snapshot (2021)
Fig. 10 Clinical trial equipment & ancillary solutions market segmentation
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Number of registered studies by year
Fig. 19 Revenue By Product (USD Million)
Fig. 20 Revenue By Product (USD Million)
Fig. 21 Clinical trial equipment & ancillary solutions market product outlook: Segment dashboard
Fig. 22 Clinical trial equipment & ancillary solutions market: Product movement analysis
Fig. 23 Sourcing market, 2018 - 2030 (USD Million)
Fig. 24 Procurement market, 2018 - 2030 (USD Million)
Fig. 25 Equipment market, 2018 - 2030 (USD Million)
Fig. 26 Ancillaries market, 2018 - 2030 (USD Million)
Fig. 27 Rental market, 2018 - 2030 (USD Million)
Fig. 28 Equipment market, 2018 - 2030 (USD Million)
Fig. 29 Ancillaries market, 2018 - 2030 (USD Million)
Fig. 30 Supply/logistics market, 2018 - 2030 (USD Million)
Fig. 31 Transportation market, 2018 - 2030 (USD Million)
Fig. 32 Packaging market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Service market, 2018 - 2030 (USD Million)
Fig. 35 Calibration market, 2018 - 2030 (USD Million)
Fig. 36 Equipment servicing market, 2018 - 2030 (USD Million)
Fig. 37 Others market, 2018 - 2030 (USD Million)
Fig. 38 Others market, 2018 - 2030 (USD Million)
Fig. 39 Global market, 2018 - 2030 (USD Million)
